Changhua Wang
Research Subjects
Changhua Wang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Hong-Bin Liu
Department of Cardiology, Chinese PLA General Hospital, Beijing, China
1 shared publicationHong-Shi Wang
Department of Cardiology, Beijing Chaoyang Hospital, Beijing, China
1 shared publicationHongbin Liu
Chinese PLA General Hospital
1 shared publication- Hui-Juan Zuo
Department of Community Health Research, Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Diseases, Capital Medical University, Beijing, China
1 shared publication - Jinwen Wang
Department of Community Health Research, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
1 shared publication Le-Feng Wang
Department of Cardiology, Beijing Chaoyang Hospital, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 31 January 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 6210204
Impact of BMI on Long‐Term Outcomes in Patients with ST‐Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention
Aim. Obesity paradox remains a point of debate in ST‐segment elevation myocardial infarction (STEMI) patients. The aim of this study was to examine the relationship between body mass index (BMI) and clinical outcomes in STEMI patients undergoing primary percutaneous coronary intervention (PPCI). Methods. Outcomes were assessed in 1429 STEMI patients undergoing PPCI between January 2009 and January 2010 in Beijing. Patients were classified into 6 groups according to age (the younger and elderly groups consisting of patients ≤65 and > 65 years old) and baseline BMI (normal weight, BMI < 24 kg/m2; overweight, 24 kg/m2 ≤BMI < 28 kg/m2; obese, BMI ≥ 28 kg/m2). The primary outcome was death, acute myocardial infarction (AMI), or revascularization. Results. On long‐term follow‐up (mean follow‐up of 59 months), 13.9% of patients experienced the adverse event. Multivariate logistic regression analyses showed that low BMI was a significant predictor of the primary outcome only in the younger group. The odds ratio for overweight in comparison with normal weight was 0.741 (95% CI: 0.413–0.979; p = 0.038), the odds radio for obesity in comparison with normal‐weight patients was 0.508 (95% CI: 0.344–0.750; p = 0.016) in the younger group. In the elderly group, diabetes, hypertension, triple disease, regular exercise, angiotensin‐converting enzyme inhibitor (ACEI) or angiotensin II receptor blockers (ARBs) use after discharge, and bleeding complication were associated with primary outcome. Conclusion. The obesity paradox was recognized only in the younger age group in STEMI patients undergoing PPCI.
- 31 January 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 6210204
Open AccessImpact of BMI on Long‐Term Outcomes in Patients with ST‐Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention
Aim. Obesity paradox remains a point of debate in ST‐segment elevation myocardial infarction (STEMI) patients. The aim of this study was to examine the relationship between body mass index (BMI) and clinical outcomes in STEMI patients undergoing primary percutaneous coronary intervention (PPCI). Methods. Outcomes were assessed in 1429 STEMI patients undergoing PPCI between January 2009 and January 2010 in Beijing. Patients were classified into 6 groups according to age (the younger and elderly groups consisting of patients ≤65 and > 65 years old) and baseline BMI (normal weight, BMI < 24 kg/m2; overweight, 24 kg/m2 ≤BMI < 28 kg/m2; obese, BMI ≥ 28 kg/m2). The primary outcome was death, acute myocardial infarction (AMI), or revascularization. Results. On long‐term follow‐up (mean follow‐up of 59 months), 13.9% of patients experienced the adverse event. Multivariate logistic regression analyses showed that low BMI was a significant predictor of the primary outcome only in the younger group. The odds ratio for overweight in comparison with normal weight was 0.741 (95% CI: 0.413–0.979; p = 0.038), the odds radio for obesity in comparison with normal‐weight patients was 0.508 (95% CI: 0.344–0.750; p = 0.016) in the younger group. In the elderly group, diabetes, hypertension, triple disease, regular exercise, angiotensin‐converting enzyme inhibitor (ACEI) or angiotensin II receptor blockers (ARBs) use after discharge, and bleeding complication were associated with primary outcome. Conclusion. The obesity paradox was recognized only in the younger age group in STEMI patients undergoing PPCI.
- 28 April 2011
- Published by Springer Nature in Heart and Vessels
- Vol. 27 (3) , 243-249
Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention
Independent no-reflow predictors should be evaluated in female patients with ST-segment elevation acute myocardial infarction (STEMI) and successfully treated with primary percutaneous coronary intervention (PPCI) in the current interventional equipment and techniques, thus to be constructed a no-reflow predicting model. In this study, 320 female patients with STEMI were successfully treated with PPCI within 12 h after the onset of AMI from 2007 to 2010. All clinical, angiographic, and procedural data were collected. Multiple logistic regression analysis was used to identify independent no-reflow predictors. The no-reflow was found in 81 (25.3%) of 320 female patients. Univariate and multivariate stepwise logistic regression analysis identified that low SBP on admission 20 mm (OR 1.948, 95% CI 1.908–1.990; p = 0.016), collateral circulation 0–1 (OR 1.952, 95% CI 1.914–1.992; p = 0.019), pre-PCI thrombus score ≥4 (OR 4.184, 95% CI 1.482–11.813; p = 0.007), and IABP use before PCI (OR 1.949, 95% CI 1.168–3.253; p = 0.011) were independent no-reflow predictors. The no-reflow incidence significantly increased as the numbers of independent predictors increased [0% (0/2), 10.8% (9/84), 14.5% (17/117), 37.7% (29/77), 56.7% (17/30), and 81.8% (9/11) in female patients with 0, 1, 2, 3, 4, and 5 independent predictors, respectively; p < 0.0001]. The five no-reflow predicting variables were admission SBP 20 mm, collateral circulation 0–1, pre-PCI thrombus score ≥4, and IABP use before PCI in female patients with STEMI treated with PPCI.
- 28 April 2011
- Published by Springer Nature in Heart and Vessels
- Vol. 27 (3) , 243-249
Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention
Independent no-reflow predictors should be evaluated in female patients with ST-segment elevation acute myocardial infarction (STEMI) and successfully treated with primary percutaneous coronary intervention (PPCI) in the current interventional equipment and techniques, thus to be constructed a no-reflow predicting model. In this study, 320 female patients with STEMI were successfully treated with PPCI within 12 h after the onset of AMI from 2007 to 2010. All clinical, angiographic, and procedural data were collected. Multiple logistic regression analysis was used to identify independent no-reflow predictors. The no-reflow was found in 81 (25.3%) of 320 female patients. Univariate and multivariate stepwise logistic regression analysis identified that low SBP on admission 20 mm (OR 1.948, 95% CI 1.908–1.990; p = 0.016), collateral circulation 0–1 (OR 1.952, 95% CI 1.914–1.992; p = 0.019), pre-PCI thrombus score ≥4 (OR 4.184, 95% CI 1.482–11.813; p = 0.007), and IABP use before PCI (OR 1.949, 95% CI 1.168–3.253; p = 0.011) were independent no-reflow predictors. The no-reflow incidence significantly increased as the numbers of independent predictors increased [0% (0/2), 10.8% (9/84), 14.5% (17/117), 37.7% (29/77), 56.7% (17/30), and 81.8% (9/11) in female patients with 0, 1, 2, 3, 4, and 5 independent predictors, respectively; p < 0.0001]. The five no-reflow predicting variables were admission SBP 20 mm, collateral circulation 0–1, pre-PCI thrombus score ≥4, and IABP use before PCI in female patients with STEMI treated with PPCI.
- 17 February 2011
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 45 (2) , 98-104
A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting
Objectives. This study was undertaken to assess independent no-reflow predictors in patients with ST-elevation acute myocardial infarction (STEMI) and primary drug-eluting stenting in the current interventional strategies. Design. One thousand four hundred and thirteen patients with STEMI were successfully treated with primary drug-eluting stenting within 12 h after AMI. All clinical, angiographic and procedural data were collected. Univariate and multivariate logistic regression was used to identify independent no-reflow predictors. Results. The no-reflow was found in 297 (21%) of 1413 patients. Univariate and multivariate logistic regression identified that age (>65 years, OR 1.47, 95% CI 1.46–1.49; p = 0.007), long time-to-reperfusion (>6 h, OR 1.27, 95% CI 1.16–1.40; p = 0.001), admission plasma glucose (>13.0 mmol/L, OR 1.27, 95% CI 1.16–1.40; p = 0.027), collateral circulation (0–1, OR 1.69, 95% CI 1.25–2.29; p = 0.001), pre-PCI thrombus score (≥4, OR 1.36, 95% CI 1.16–1.79; p = 0.011), and IABP use before PCI (OR 2.89, 95% CI 1.65–5.05; p < 0.0001) were independent no-reflow predictors. The no-reflow rate significantly increased as the number of independent predictors increased (0%, 6%, 15%, 25%, 40%, 50% and 100% in patients with 0, 1, 2, 3, 4, 5, and 6 independent predictors, respectively; p < 0.0001). Conclusions. The prediction model consisted of six no-reflow predictors in patients with STEMI and primary drug-eluting stenting and should be confirmed in large-scale prospective studies.
- 17 February 2011
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 45 (2) , 98-104
A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting
Objectives. This study was undertaken to assess independent no-reflow predictors in patients with ST-elevation acute myocardial infarction (STEMI) and primary drug-eluting stenting in the current interventional strategies. Design. One thousand four hundred and thirteen patients with STEMI were successfully treated with primary drug-eluting stenting within 12 h after AMI. All clinical, angiographic and procedural data were collected. Univariate and multivariate logistic regression was used to identify independent no-reflow predictors. Results. The no-reflow was found in 297 (21%) of 1413 patients. Univariate and multivariate logistic regression identified that age (>65 years, OR 1.47, 95% CI 1.46–1.49; p = 0.007), long time-to-reperfusion (>6 h, OR 1.27, 95% CI 1.16–1.40; p = 0.001), admission plasma glucose (>13.0 mmol/L, OR 1.27, 95% CI 1.16–1.40; p = 0.027), collateral circulation (0–1, OR 1.69, 95% CI 1.25–2.29; p = 0.001), pre-PCI thrombus score (≥4, OR 1.36, 95% CI 1.16–1.79; p = 0.011), and IABP use before PCI (OR 2.89, 95% CI 1.65–5.05; p < 0.0001) were independent no-reflow predictors. The no-reflow rate significantly increased as the number of independent predictors increased (0%, 6%, 15%, 25%, 40%, 50% and 100% in patients with 0, 1, 2, 3, 4, 5, and 6 independent predictors, respectively; p < 0.0001). Conclusions. The prediction model consisted of six no-reflow predictors in patients with STEMI and primary drug-eluting stenting and should be confirmed in large-scale prospective studies.